Xenetic Biosciences, Inc. (XBIO): Total Assets
$8.36M
As of 2025-12-31
$6.97M
As of 2026-06-30
-17.2%
3-year compound annual growth
-8.7%
5-year compound annual growth
-6.8%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.36M | +21.2% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $6.90M | -34.9% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $10.61M | -28.0% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $14.72M | -25.7% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $19.82M | +50.3% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $13.18M | -38.8% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $21.55M | +49.3% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $14.43M | -24.7% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $19.16M | -8.6% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $20.97M | +24.0% | 2018-03-30, Balance as of period end |
| 2015-12-31 | $16.91M | +3.6% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $16.32M | -16.2% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $19.47M | n/a | 2015-07-20, Balance as of period end |
| 2013-08-31 | $486.8K | n/a | 2013-11-27, Balance as of period end |
| 2012-12-31 | $25.37M | n/a | 2015-07-20, Balance as of period end |
| 2012-08-31 | $324.1K | n/a | 2013-11-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $37.66M | -3.0% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $353.77M | -26.6% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $296.41M | -31.9% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $19.07M | -13.4% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $6.34M | -22.2% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $31.00M | +108.2% |
Compare XBIO, TXMD, UPB, RNAC side by side · Screen every company in Pharmaceutical Preparations ↗